Pet Drug Reports

Sarolaner: adverse event reports in all combinations

Active ingredient, alone and in combinations

Brand names with this ingredient: Simparica, Revolution Plus.

The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.

Read this first. FDA says this about the data:

An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another. When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event. This dataset should not be the sole source of information for clinical decision-making or other assumptions about the safety or effectiveness of a product. The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.

FDA Center for Veterinary Medicine publishes these words. Source: Adverse Event Reports for Animal Drugs and Devices, read on . The data have the reports that FDA received through .

This page is not veterinary advice. For an animal that is ill, speak to a veterinarian.

Contacting a veterinarianHow to report to FDA

FDA reports received through . Counts include this ingredient alone and in combinations. Why brand names have no separate count.

From March 2016 to June 2026, FDA received 83,355 adverse event reports that name a drug with sarolaner, alone or in a combination. 4 sets of active ingredients with sarolaner have a drug page.

Of the 83,355 reports, 70,960 (85.1%) are about dogs. 8,529 reports are about cats (10.2%). In January to March 2026, FDA received 2,822 reports that name sarolaner, alone or in a combination. The signs that appear in the largest number of the 83,355 reports are "Vomiting", "Seizure NOS" and "Lack of efficacy (bacteria) - Borrelia". A report is not proof that a drug caused a sign.

Reports that name this ingredient fell by 4.6% in the 12 months to June 2026, compared with the 12 months before. Reports for all animal drugs fell by 4.6% in the same periods. The newest months can get more reports in a later update. Reports about dogs are 85.1% of the reports that name this ingredient, and 72.6% of all reports.

Reports in the latest closed quarter

Reports that name sarolaner, by the quarter in which FDA received them
SpeciesJan to Mar 2026Oct to Dec 2025Jan to Mar 2025
All species2,8222,8942,672
Dog2,4622,5192,342
Cat250268236
Horse000
Other or not given11010794

January to March 2026 is the latest closed quarter in the data.

All updatesFeed of updates (RSS)

Drug pages with sarolaner

A report names a drug by its set of active ingredients. Each set with sarolaner that has a drug page is in the table, in order of name. The table has 4 sets.

Drug pages with sarolaner, in order of name, with the reports of each page
Active ingredientsReports, all yearsReports, latest 12 months
Moxidectin + Pyrantel Pamoate + Sarolaner1,191373
Pyrantel Pamoate + Sarolaner55,02510,254
Sarolaner17,585835
Sarolaner + Selamectin9,8281,306

A report can name more than one set, so the counts of the sets can add to more than the count of the page.

An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another.

FDA Center for Veterinary Medicine. Source: Adverse Event Reports for Animal Drugs and Devices

Signs that the reports list

A sign is a coded term from the report. The words in brackets are a plain gloss of the term. The percentage is the share of the 83,355 reports that list the sign. One report can list more than one sign and more than one drug.

The sign that is in the largest number of the reports comes first.

  1. Vomiting16.8%13,988 reports
  2. Seizure NOS[seizure, type not specified]9%7,529 reports
  3. Lack of efficacy (bacteria) - Borrelia[the product did not have the expected effect: Borrelia (Lyme disease bacteria)]8.6%7,196 reports
  4. Lethargy[unusually tired or inactive]7.9%6,613 reports
  5. Lack of efficacy (endoparasite) - heartworm[the product did not have the expected effect: heartworm]7.8%6,464 reports
  6. Diarrhoea[diarrhea]6.9%5,713 reports
  7. Lack of efficacy (endoparasite) - hookworm[the product did not have the expected effect: hookworms]5.6%4,682 reports
  8. Lack of efficacy (ectoparasite) - tick NOS[the product did not have the expected effect: ticks]5.4%4,516 reports
  9. Lack of efficacy (endoparasite) - roundworm NOS[the product did not have the expected effect: roundworms]4.3%3,607 reports
  10. Lack of efficacy (ectoparasite) - flea[the product did not have the expected effect: fleas]4.2%3,539 reports
  11. Lack of efficacy (endoparasite) - tapeworm[the product did not have the expected effect: tapeworms]3.2%2,693 reports
  12. Tremor3.2%2,637 reports
  13. Application site hair loss[hair loss where the product was applied]2.9%2,399 reports
  14. Ataxia[unsteady, uncoordinated movement]2.7%2,273 reports
Show the next 16 signs
  1. Intentional misuse[use that was knowingly different from the label]2.6%2,194 reports
  2. Lack of efficacy (bacteria) - Anaplasma[the product did not have the expected effect: Anaplasma bacteria]2.6%2,174 reports
  3. Medication error NOS[a mistake in giving the product, type not specified]2.5%2,057 reports
  4. Anorexia[not eating]2.1%1,711 reports
  5. Not eating2%1,707 reports
  6. Behavioural disorder NOS[behaviour change, type not specified]1.8%1,527 reports
  7. Lack of efficacy (bacteria) - Ehrlichia[the product did not have the expected effect: Ehrlichia bacteria]1.8%1,494 reports
  8. Emesis (multiple)[vomiting more than once]1.6%1,367 reports
  9. Shaking1.6%1,332 reports
  10. Decreased appetite1.5%1,263 reports
  11. Lack of efficacy (bacteria) - NOS[the product did not have the expected effect: target not specified]1.4%1,160 reports
  12. Twitching1.2%1,013 reports
  13. Lack of efficacy (endoparasite) - whipworm[the product did not have the expected effect: whipworms]1.1%933 reports
  14. Underfilling, Container[a product quality report, not a sign in an animal]1.1%911 reports
  15. Lack of efficacy (tick)[the product did not have the expected effect: ticks]1%860 reports
  16. Death1%857 reports

Download all signs (CSV)

Reports by species

  • Dog85.1%70,960
  • Cat10.2%8,529
  • Human exposure0.2%148
  • Rabbitunder 0.1%3
  • Bobcatunder 0.1%2
  • Lynxunder 0.1%2

Reports for each month, Jul 2021 to Jun 2026

Dog54,584 reports. Largest count in one month: 1,214 (Jun 2023)
Cat5,654 reports. Largest count in one month: 139 (Aug 2023)
Horse0 reports

No chart: no month has 5 or more reports.

Other or not given2,835 reports. Largest count in one month: 73 (May 2023)

The month is the month in which FDA received the report. Each chart has its own scale. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.

Reports by year

  • Dog
  • Cat
  • Horse
  • Other or not given
Reports that name sarolaner, by the year in which FDA received them and by species
YearDogCatHorseOther or not givenAll species
20265,46255202246,238
202511,5801,157050113,238
202411,6381,205057813,421
202311,2111,142068113,034
202210,431970061012,011
20218,2051,22404379,866
20204,2541,21003545,818
20192,89199302404,124
20182,8503701293,016
20171,998350972,130
20164404015459

2026 has the reports that FDA received through Jun 2026. Download the years (CSV)

What the reports record

Outcome at the time of the report

  • Recovered/Normal18.6%15,538
  • Recovered with Sequela[recovered, with a lasting effect]under 0.1%41
  • Ongoing52.3%43,578
  • Died1.1%954
  • Euthanized0.9%779
  • Outcome Unknown22.6%18,805

An outcome in a report is not proof that the drug caused it. The person who sends the report gives the outcome. Each share is of the 83,355 reports that name sarolaner.

Kind of report

  • Safety issue52.1%43,469
  • Lack of expected effectiveness39.7%33,105
  • Both safety and lack of expected effectiveness3.3%2,718
  • Manufacturing or product defect4.8%3,978
  • Other0.1%85

Age of the animal

  • Under 1 year12.8%10,679
  • 1 to 3 years33.2%27,697
  • 4 to 7 years21.3%17,773
  • 8 to 11 years13.4%11,186
  • 12 years and over6.9%5,745
  • Age not given12.3%10,275

Each share of kind and age is of the 83,355 reports that name sarolaner.

Approved animal drugs with this active ingredient (FDA Green Book)

This section is reference data. It has no report count.

The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.

Brand names

  • Simparica
  • Revolution Plus

What the Green Book records give

Applications with an approval in force
3
Approved species
Dogs, Cats
Dose forms
Chewable Tablets, Topical Solution
Routes
Oral, Topical
Sale
RX (prescription)
Earliest approval date in the records

The species, dose forms and routes are the words of the Green Book records for all the applications together. One product can have fewer. The label of a product gives its approved use.

Applications in the Green Book of 2 Nov 2026, pioneer applications (NADA) first
Brand nameActive ingredientsSponsorApproved speciesApplication
SimparicaSarolanerZoetis Inc.DogsNADA 141-452
Revolution PlusSarolaner, SelamectinZoetis Inc.CatsNADA 141-502
Simparica TrioMoxidectin, Pyrantel Pamoate, SarolanerZoetis Inc.DogsNADA 141-521

FDA pages for this ingredient

The site checked these addresses on . The links open in a new tab.

Cite this page

Pet Drug Reports. Sarolaner, all combinations: adverse event reports that FDA received. https://petdrugreports.com/ingredient/sarolaner/ Source: FDA Center for Veterinary Medicine, openFDA Animal and Veterinary adverse event reports, export of . Reports received through .

Embed this card on your site

Copy this code into your page. The card shows the figures above with their source. A line under the card links to this page.

How embedding works. It is free. Keep the link in the card and the link line under it.

Where the data come from

The counts come from the openFDA Animal and Veterinary adverse event files, export of 30 Oct 2026. The files have the reports that the FDA Center for Veterinary Medicine received through 26 Jun 2026. The files mask brand and manufacturer names. The site counts a drug by the active ingredients that each record gives, and gives no count to a brand, an application or a company. Ingredient names and the lists of approved products follow the FDA Green Book of 2 Nov 2026. Ingredient names follow the Green Book, with salts and forms as FDA lists them.

The site does not publish report text, lot numbers or details of a reporter. FDA's record is the authority. See how the site counts reports, the data sources and the corrections page.

Questions about these reports

Which brand are these reports about?

The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand. The Green Book section of this page lists brand names with this active ingredient.

Do the reports show that the ingredient caused the signs?

No. A report can name more than one drug, and a drug can have more than one active ingredient. FDA states this about the data.

When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event.

The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.

FDA Center for Veterinary Medicine. Source: Adverse Event Reports for Animal Drugs and Devices

How many reports did FDA receive in the latest 12 months?

FDA received 12,749 reports in the 12 months to June 2026. It received 13,360 reports in the 12 months before. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.

What kinds of report are in the count?

Of the 83,355 reports received from March 2016 to June 2026, 52.1% are about a safety issue only. 43% are about a lack of expected effectiveness, alone or with a safety issue. 4.8% are about a defect of the product or its package.